1. Corporate Officers - W
2. Wolff Stefani

Insider Trading History of Wolff Stefani

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wolff Stefani since 2019. This trader's CIK number is 1751790. At the time of last reporting, Wolff Stefani was the EVP and COO of Nurix Therapeutics, Inc.. (stock ticker symbol NRIX). Also see all insider trading activities at Nurix Therapeutics, Inc..

Note that in the past Wolff Stefani also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Nurix Therapeutics, Inc. (NRIX) by Wolff Stefani

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2023	NRIX	0	$0	766	$8,371	1,924	$0
2022	NRIX	0	$0	1,036	$13,963	2,886	$0

Yearly summary of insider trading at Principia Biopharma Inc. (PRNB) by Wolff Stefani

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2020	PRNB	0	$0	11,008	$587,430	5,504	$24,999
2019	PRNB	0	$0	5,505	$272,926	5,505	$25,003

Insider trading activities at 2 companies by Wolff Stefani:

1. Nurix Therapeutics, Inc. (NRIX)

2. Principia Biopharma Inc. (PRNB)

Table 1. Insider trading of Nurix Therapeutics, Inc. (NRIX) by Wolff Stefani

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2023-04-30	NRIX	Option Ex	962	.00	0
2023-05-01	NRIX	Sale	342	9.88	3,377
2023-01-30	NRIX	Option Ex	962	.00	0
2023-01-30	NRIX	Sale	424	11.78	4,994
2022-10-31	NRIX	Sale	350	12.88	4,508
2022-10-30	NRIX	Option Ex	962	.00	0
2022-07-30	NRIX	Option Ex	962	.00	0
2022-08-01	NRIX	Sale	356	15.67	5,578
2022-04-30	NRIX	Option Ex	962	.00	0
2022-05-02	NRIX	Sale	330	11.75	3,877

Table 2. Insider trading of Principia Biopharma Inc. (PRNB) by Wolff Stefani

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2020-06-15	PRNB	Sale	5,504	60.69	334,037
2020-03-16	PRNB	Option Ex	5,504	4.54	24,999
2020-03-16	PRNB	Sale	5,504	46.04	253,393
2019-12-16	PRNB	Option Ex	5,505	4.54	25,003
2019-12-16	PRNB	Sale	5,505	49.58	272,926

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wolff Stefani (EVP and COO of Nurix Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month